Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers

Schwarz, 1909, über Desensibiliserung gegen Röntgen- und Radiumstrahlen, Munchener Medizinische Wochenschrift, 24, 1

Schwarz, 1914, Merkwürdige Schwankungen der Röntgenempfindlichkeit bein einem und demselben Patienten, Wiener Medizinische Wochenschrift, 64, 2597

Müller, 1910, Eine neue Behandlungsmethode bösartiger Geschwülste, Munchener Medizinische Wochenschrift, 28, 1490

Gray, 1953, The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy, Br J Radiol, 26, 638, 10.1259/0007-1285-26-312-638

Thomlinson, 1955, The histological structure of some human lung cancers and the possible implications for radiotherapy, Br J Cancer, 9, 539, 10.1038/bjc.1955.55

Tannock, 1968, The relationship between cell proliferation and the vascular system in a transplanted mouse mammary tumour, Br J Cancer, 22, 258, 10.1038/bjc.1968.34

Horsman, 1992, Overcoming tumour radiation resistance resulting from acute hypoxia, Eur J Cancer, 28A, 717, 10.1016/0959-8049(92)90099-N

Brown, 1979, Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation, Br J Radiol, 52, 650, 10.1259/0007-1285-52-620-650

Chaplin, 1987, Intermittent blood flow in a murine tumor: radiobiological effects, Cancer Res, 47, 597

Horsman, 1995, Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours, Acta Oncologica, 34, 571, 10.3109/02841869509094031

Moulder, 1984, Hypoxic fractions of solid tumour, Int J Radiat Oncol Biol Phys, 10, 695, 10.1016/0360-3016(84)90301-8

Horsman, 1993, Relationship between radiobiological hypoxia in clonogenic tumour cells and direct estimates of tumour oxygenation in a mouse tumour model, Radiother Oncol, 28, 69, 10.1016/0167-8140(93)90188-E

Overgaard, 1989, Sensitization of hypoxic tumour cells-clinical experience, Int J Radiat Biol, 56, 801, 10.1080/09553008914552081

Kolstad, 1963

Gatenby, 1988, Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy, Int J Radiat Oncol Biol Phys, 14, 831, 10.1016/0360-3016(88)90002-8

Höckel, 1993, Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix, Radiother Oncol, 26, 45, 10.1016/0167-8140(93)90025-4

Nordsmark, 1994, Measurement of human tumour oxygenation status by a polarographic needle electrode, Acta Oncologica, 33, 383, 10.3109/02841869409098433

Du Sault, 1963, The effect of oxygen on the response of spontaneous tumours in mice to radiotherapy, Br J Radiol, 36, 749, 10.1259/0007-1285-36-430-749

Suit, 1972, Oxygen, oxygen plus carbon dioxide, and radiation therapy of a mouse mammary carcinoma, Cancer, 30, 1154, 10.1002/1097-0142(197211)30:5<1154::AID-CNCR2820300503>3.0.CO;2-5

Siemann, 1977, The importance of the pre-irradiation breathing times of oxygen and carbogen (5% CO2; 95% O2) on the in vivo radiation response of a murine sarcoma, Int J Radiat Oncol Biol Phys, 2, 903, 10.1016/0360-3016(77)90188-2

Rojas, 1991, Radiosensitization with normobaric oxygen and carbogen, Radiother Oncol, 20, 65, 10.1016/0167-8140(91)90190-R

Grau, 1992, Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen and carbogen breathing, Int J Radiat Oncol Biol Phys, 22, 415, 10.1016/0360-3016(92)90844-8

Churchill-Davidson, 1968, The oxygen effect in radiotherapy-historical review, Frontiers of Radiation Therapeutic Oncology, 1, 1

Dische, 1983, Carcinoma of the cervix-anaemia, radiotherapy and hyperbaric oxygen, Br J Radiol, 56, 251, 10.1259/0007-1285-56-664-251

Dische, 1979, Hyperbaric oxygen: the Medical Research Council trials and their clinical significance, Br J Radiol, 51, 888, 10.1259/0007-1285-51-611-888

Henk, 1981, Does hyperbaric oxygen have a future in radiation therapy?, Int J Radiat Oncol Biol Phys, 7, 1125, 10.1016/0360-3016(81)90173-5

Henk, 1977, Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial, Lancet, 313, 101, 10.1016/S0140-6736(77)90116-7

Henk, 1977, Radiotherapy and hyperbaric oxygen in head and neck cancer. Interim report of second clinical trial, Lancet, 313, 104, 10.1016/S0140-6736(77)90117-9

Watson, 1978, Hyperbaric oxygen and radiotherapy: A medical research council trial in carcinoma of the cervix, Br J Radiol, 51, 879, 10.1259/0007-1285-51-611-879

Bergsjø, 1968, Clinical trial with atmospheric oxygen breathing during radiotherapy of cancer of the cervix, Scand J Clin Lab Invest, 106, 167, 10.1080/00365516809168212

Rubin, 1979, Carbogen breathing during radiation therapy. The RTOG study, Int J Radiat Oncol Biol Phys, 5, 1963, 10.1016/0360-3016(79)90946-5

Horsman, 1994, The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment, XVI, 635

Adams, 1969, Electron-affinic sensitization. I. A structural basis for chemical radiosensitizers in bacteria, Int J Radiat Biol, 15, 457

Adams, 1976, Electron-affinic sensitization VII: A correlation between structures, oneelectron reduction potentials and efficiencies of some nitroimidazoles as hypoxic cell radiosensitizers, Radiat Res, 67, 9, 10.2307/3574491

Asquith, 1974, Electron-affinic sensitization V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles, Radiat Res, 60, 108, 10.2307/3574010

Overgaard, 1994, Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors, Oncology Research, 6, 509

Dische, 1985, Chemical sensitizers for hypoxic cells: a decade of experience in clinical radiotherapy, Radiother Oncol, 3, 97, 10.1016/S0167-8140(85)80015-3

Overgaard, 1991, The Danish Head and Neck Cancer study group (DAHANCA) randomized trials with hypoxic radiosensitizers in carcinoma of the larynx and pharynx, Volume II, 573

Dische, 1993, A trial of Ro 03-8799 (pimonidazole) in carcinoma of the uterine cervix: an interim report from the Medical Research Council Working Party on advanced carcinoma of the cervix, Radiother Oncol, 26, 93, 10.1016/0167-8140(93)90089-Q

Lee, 1995, Results of RTORTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole (SR-2508) with radiotherapy alone for locally advanced head and neck carcinomas, Int J Radiat Oncol Biol Phys, 32, 567, 10.1016/0360-3016(95)00150-W

Overgaard, 1982, A comparative investigation of nimorazole and misonidazole as a hypoxic radiosensitizer in a C3H mammary carcinoma in vivo, Br J Cancer, 46, 904, 10.1038/bjc.1982.300

Overgaard, 1993, Advances in clinical applications of radiobiology: phase III studies of radiosensitizers and novel fractionation schedules, Volume III, 863

Hirst, 1986, Anemia: A problem or an opportunity in radiotherapy?, Int J Radiat Oncol Biol Phys, 12, 2009, 10.1016/0360-3016(86)90139-2

Overgaard, 1988, The influence of hemoglobin concentration on the response to radiotherapy, Scand J Clin Lab Invest, 48, 49, 10.1080/00365518809168189

Dische, 1991, Radiotherapy and anaemia—the clinical experience, Radiother Oncol, 20, 35, 10.1016/0167-8140(91)90184-I

Overgaard, 1989, Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the Dahanca 2 study, Int J Radiat Oncol Biol Phys, 16, 1065, 10.1016/0360-3016(89)90917-6

Dische, 1986, Hemoglobin, radiation, morbidity and survival, Int J Radiat Oncol Biol Phys, 12, 1335, 10.1016/0360-3016(86)90166-5

Bush, 1986, The significance of anemia in clinical radiation therapy, Int J Radiat Oncol Biol Phys, 12, 2047, 10.1016/0360-3016(86)90146-X

Sealy, 1989, The treatment of tumours by the induction of anemia and irradiation in hyperbaric oxygen, Cancer, 64, 646, 10.1002/1097-0142(19890801)64:3<646::AID-CNCR2820640314>3.0.CO;2-J

Coleman, 1988, Hypoxia in tumors: A paradigm for the approach to biochemical and physiologic heterogeneity, J Nat Cancer Inst, 80, 310, 10.1093/jnci/80.5.310

Lavey, 1993, Erythropoietin increased hemoglobin in cancer patients during radiation therapy, Int J Radiat Oncol Biol Phys, 27, 1147, 10.1016/0360-3016(93)90536-5

Overgaard, 1992, Tumour oxygen unloading capacity in patients with squamous cell carcinoma in head and neck, Int J Radiat Oncol Biol Phys, 22, 407, 10.1016/0360-3016(92)90842-6

Browman, 1993, Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer, New Engl J Med, 328, 159, 10.1056/NEJM199301213280302

Horsman, 1993, Hypoxia in tumours: Its relevance, identification and modification, 99

Horsman, 1990, Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells, Cancer Res, 50, 7430

Horsman, 1993, Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy, Radiother Oncol, 27, 131, 10.1016/0167-8140(93)90133-S

Overgaard, 1995, Modification of hypoxia-from Gottwald Schwarz to nicotinamide. Have we learned the lesson?, V, 469

Bentzen, 1994, Radiobiological considerations in the design of clinical trials, Radiother Oncol, 32, 1, 10.1016/0167-8140(94)90443-X

Nordsmark, 1995, Oxygenation status predicts radiation response in advanced squamous cell carcinoma of head and neck, Eur J Cancer, 10.1016/0959-8049(95)95736-P